Darius Widera

Degree of title: 
Assistant professor
Organization: 
School of Pharmacy, University of Reading, United Kingdom
Topic : 
Exosomes of Neural Crest-Derived Stem Cells as a Novel Approach to Stimulate Bone Regeneration through Regulation of Osteogenesis and Angiogenesis
Time of report: 
17 November, Friday - 10:20

Assistant Professor in Stem Cell Biology and Regenerative Medicine, School of Pharmacy, University of Reading, United Kingdom

Visiting Professor, Stavropol State Medical University Russian Federation

Dr Widera is an Assistant Professor at the University of Reading, United Kingdom. His lab is mainly interested in adult stem cells and their secretome, inflammatory signaling cascades in health and disease, and novel methods for clinical grade 3D-cultivation of human stem cells.

He graduated in Biochemistry (Witten/Herdecke University, Germany) and received his PhD in Neurobiochemistry from the Witten/Herdecke University in Germany in 2007. From 2013 to 2015 he served as a Principal Investigator and Adjunct Professor at the Department of Cell Biology, University of Bielefeld (Germany). In February 2015 he was appointed Lecturer in Stem Cell Biology and Regenerative Medicine at the University of Reading, where his lab is currently based. Since May 2015 he also serves as a Visiting Professor at the Stavropol State Medical University (Russian Federation).

He has published over 45 PubMed/Scopus-listed publications (1605 citations, h-factor of 19) in addition to several book chapters and has presented his research outcomes as invited talks at numerous international conferences in the UK, Germany, USA, Russia, Malaysia, Singapore, Brazil, and China.

In addition, he serves as an Associate Editor for the journal Frontiers in Stem Cell Research and acts as an ad-hoc peer reviewer for funding bodies including the British Council (UK), DEBRA International, German Academic Exchange Service (Germany), National Medical Research Council (NMRC, Singapore), The Daphne Jackson Trust (United Kingdom), and renowned journals including Biomaterials, Langmuir, Stroke, Stem Cells, and European Cells and Materials.